Wafaa M Rashed: Advocacy for Genetic Risk Assessment in Breast and Prostate Cancer
Wafaa M Rashed and Esther Elikplim Gomado

Wafaa M Rashed: Advocacy for Genetic Risk Assessment in Breast and Prostate Cancer

Wafaa M Rashed, Chair and Founder of Pan-African PGS Education and Research Initiative, shared a post on LinkedIn:

” New Blog Alert from PAPERI

We are proud to share the second blog by Esther Elikplim Gomado (Ghana) – a graduate of the Policy Advocacy in Genetics and Genomics Course, proudly sponsored by PAPERI.

Advocacy for Genetic Risk Assessment in Breast and Prostate Cancer

In this powerful and evidence-driven piece, Esther highlights a critical gap in cancer care across Africa – the limited access to genetic risk assessment for hereditary cancers such as breast and prostate cancer.

She explores:

  • The life-saving potential of BRCA1/2 genetic testing
  • The urgent need for policy reform and investment in genomic infrastructure
  • Systemic barriers including cost, workforce shortages, and limited awareness
  • Practical, Africa-centered solutions – from task-shifting in genetic counseling to community engagement strategies

Her message is clear: genetic testing is not a luxury – it is a public health necessity.
As a PAPERI-trained advocate, Esther’s work reflects the growing movement of African professionals leading change at the intersection of genomics, policy, and health equity.

Join us in celebrating her contribution and amplifying this important conversation on equitable cancer prevention in Africa.

Read the full blog.

 

Other articles featuring Wafaa M Rashed on OncoDaily.